SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-022352
Filing Date
2024-02-13
Accepted
2024-02-13 17:17:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv02328-zentalispharmaceutic.htm SC 13G/A 11488
  Complete submission text file 0001104659-24-022352.txt   13240
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

IRS No.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10275 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91478 | Film No.: 24629970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)